The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase kinase activity and shows a major autocrine component

Molecular Biology of the Cell

Volumn 15, Issue 7, 2004, Pages 3450-3463

  Schulze, Almut ^a   Nicke, Barbara ^a   Warne, Patricia H ^a   Tomlinson, Simon ^a   Downward, Julian ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKING AGENT; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BREAST EPITHELIUM; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSCRIPTION PROFILING; HUMAN; HUMAN CELL; OVARY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYDROXYTESTOSTERONES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION, GENETIC;

EID: 3042848454     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-11-0807     Document Type: Article

References (49)

1. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Baumann, B., Weber, C.K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U.R., and Wirth, T. (2000). Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc. Natl. Acad. Sci. USA 97, 4615-4620.
3. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A., and Greenberg, M.E. (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362.
4. Bos, J.L. (1989), ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689,
5. Bosch, E., Cherwinski, H., Peterson, D., and McMahon, M. (1997). Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 15, 1021-1033.
6. Chen, J., Fujii, K., Zhang, L., Roberts, T., and Fu, H. (2001). Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc. Natl. Acad. Sci. USA 98, 7783-7788.
7. de Larco, J.E., and Todaro, G.J. (1978). Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 75, 4001-4005.
8. Downward, J. (1998). Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8, 49-54.
9. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J., and Saltiel, A.R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.
10. Erhardt, P., Schremser, E.J., and Cooper, G.M. (1999). B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19, 5308-5315.
11. Fabian, J.R., Daar, I.O., and Morrison, D.K. (1993). Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13, 7170-7179.
12. Favata, M.F., et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
13. Finco, T.S., Westwick, J.K., Norris, J.L., Beg, A.A., Der, C.J., and Baldwin, A.S., Jr. (1997). Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272, 24113-24116.
14. Fry, D.W., Bridges, A.J., Denny, W.A., Doherty, A., Greis, K.D., Hicks, J.L., Hook, K.E., Keller, P.R., Leopold, W.R., Loo, J.A., et al. (1998), Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc. Natl. Acad. Sci. USA 95, 12022-12027.
15. Gire, V., Marshall, C.J., and Wynford-Thomas, D. (1999). Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18, 4819-4832.
16. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., and Taniguchi, N. (1995). Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967-980.
17. Herrera, R., and Sebolt-Leopold, J.S. (2002). Ultraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention. Trends Mol. Med. 8, S27-S31.
18. Hüser, M., Luckett, J., Chiloeches, A., Mercer, K., Iwobi, M., Giblett, S., Sun, X.M., Brown, J., Marais, R., and Pritchard, C. (2001). MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20, 1940-1951.
19. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997). Induction of apoptosis by A.S.K1, a mammalian M.A.P.K.K.K. that activates S.A.P.K/J.N.K. and p38 signaling pathways. Science 275, 90-94.
20. Jones, J.T., Akita, R.W., and Sliwkowski, M.X. (1999). Binding specificities and affinities of EGF domains for ErbB receptors. FEBS Lett. 447, 227-231.
21. Kamakura, S., Moriguchi, T., and Nishida, E. (1999). Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274, 26563-26571.
22. Kazama, H., and Yonehara, S. (2000). Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase. J. Cell Biol. 148, 557-566.
23. Kolch, W. (2000). Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351, 289-303.
24. Le Gall, M., Chambard, J.C., Breittmayer, J.P., Grall, D., Pouyssegur, J., and Van Obberghen-Schilling, E. (2000). The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 11, 1103-1112.
25. Leevers, S.J., Paterson, H.F., and Marshall, C.J. (1994). Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369, 411-414.
26. Lehmann, K., Janda, E., Pierreux, C.E., Rytomaa, M., Schulze, A., McMahon, M., Hill, C.S., Beug, H., and Downward, J. (2000). Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14, 2610-2622.
27. Li, S., and Sedivy, J.M. (1993). Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-1 kappa B complex. Proc. Natl. Acad. Sci. USA 90, 9247-9251.
28. Marais, R., and Marshall, C.J. (1996). Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27, 101-125.
29. Marshall, C. (1999). How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Opin. Cell Biol. 11, 732-736.
30. Marshall, C.J. (1996). Ras effectors. Curr. Opin. Cell Biol. 8, 197-204.
31. McCarthy, S.A., Samuels, M.L., Pritchard, C.A., Abraham, J.A., and McMahon, M. (1995). Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9, 1953-1964.
32. Mikula, M., Schreiber, M., Husak, Z., Kucerova, L., Ruth, J., Wieser, R., Zatloukal, K., Beug, H., Wagner, E.F., and Baccarini, M. (2001). Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20, 1952-1962.
33. Oldham, S.M., Clark, G.J., Gangarosa, L.M., Coffey, R.J., Jr., and Der, C.J. (1996). Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. USA 93, 6924-6928.
34. Pahl, H.L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
35. Pearson, G., Bumeister, R., Henry, D.O., Cobb, M.H., and White, M.A. (2000). Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. J. Biol. Chem. 275, 37303-37306.
36. Pruitt, K., Pruitt, W.M., Bilter, G.K., Westwick, J.K., and Der, C.J. (2002). Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation. J. Biol. Chem. 277, 31808-31817.
37. Sa, G., Murugesan, G., Jaye, M., Ivashchenko, Y., and Fox, P.L. (1995). Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270, 2360-2366.
38. Schulze, A., Lehmann, K., Jefferies, H.B., McMahon, M., and Downward, J. (2001). Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15, 981-994.
39. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F.M., Schlessinger, J., and Wagner, E.F. (2000). The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211-220.
40. Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D., Jr., Brenz, R., McGrath, C.M., Russo, J., Pauley, R.J., Jones, R.F., and Brooks, S.C. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086.
41. Tang, E.D., Nunez, G., Barr, F.G., and Guan, K.L. (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741-16746.
42. Tang, T.T., Dowbenko, D., Jackson, A., Toney, L., Lewin, D.A., Dent, A.L., and Lasky, L.A. (2002). The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem. 277, 14255-14265.
43. Treisman, R. (1996). Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8, 205-215.
44. Troppmair, J., Hartkamp, J., and Rapp, U.R. (1998). Activation of NF-kappa B by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade. Oncogene 17, 685-690.
45. Tsao, S.W., Mok, S.C., Fey, E.G., Fletcher, J.A., Want, T.S., Chew, E.C., Muto, M.G., Knapp, R.C., and Berkowitz, R.S. (1995). Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp. Cell Res. 218, 499-507.
46. Vale, T., Ngo, T.T., White, M.A., and Lipsky, P.E. (2001). Raf-induced transformation requires an interleukin I autocrine loop. Cancer Res 61, 602-607.
47. Wang, H.G., Rapp, U.R., and Reed, J.C. (1996a). Bcl-2 targets the protein kinase Raf-I to mitochondria. Cell 87, 629-638.
48. Wang, X.S., Diener, K., Jarmuzzi, D., Trollinger, D., Tan, T.H., Lichenstein, H., Zukowski, M., and Yao, Z. (1996b). Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase. J. Biol. Chem. 277, 31607-31611.
49. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598-5611.